Stereotactic ablative radiotherapy (SABR) has been recognized as a standard alternative treatment to surgery for inoperable early stage non-small cell lung cancer (NSCLC). Guaranteed local control rates over 90
作者:Jingze, Zhang;Li, Kong;Qinghua, Jiao;Minghuan, Li;Jingming, Yu
来源:Cancer letters 2017 年 401卷